Ingles Markets Inc (IMKTA) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, IMKTA trades at $86.51 with a market cap of $1.63B and a P/E ratio of 0.00. IMKTA moved -1.57% today. Year to date, IMKTA is +24.83%; over the trailing twelve months it is +40.37%. Its 52-week range spans $58.92 to $95.62. Rallies surfaces IMKTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in IMKTA news today?
Ingles Markets Highlights 60-Year Performance, Urges Rejection of Sackler Nominee: Ingles Markets issued an investor presentation for its April 30, 2026 Annual Meeting, spotlighting 60-year market leadership, 197 supermarkets in six states and improved fiscal Q1 results from vertical integration. The company urges shareholders to reject Sacklers’ Summer Road nominee and support its candidates, Rebekah Lowe and Dwight Jacobs.
Ingle Sharp Laura sold 5.90K (~$401.41K) on Jun 27, 2024.
Ingle Sharp Laura sold 4.80K (~$337.75K) on Jun 24, 2024.
Ingle Sharp Laura sold 4.00K (~$281.52K) on Jun 11, 2024.
IMKTA Analyst Consensus
IMKTA analyst coverage data. Average price target: $0.00.
Common questions about IMKTA
What changed in IMKTA news today?
Ingles Markets Highlights 60-Year Performance, Urges Rejection of Sackler Nominee: Ingles Markets issued an investor presentation for its April 30, 2026 Annual Meeting, spotlighting 60-year market leadership, 197 supermarkets in six states and improved fiscal Q1 results from vertical integration. The company urges shareholders to reject Sacklers’ Summer Road nominee and support its candidates, Rebekah Lowe and Dwight Jacobs.
Does Rallies summarize IMKTA news?
Yes. Rallies summarizes IMKTA news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is IMKTA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IMKTA. It does not provide personalized investment advice.
